Renal and Red Marrow Dosimetry in Peptide Receptor Radionuclide Therapy: 20 Years of History and Ahead

The development of dosimetry and studies in peptide receptor radionuclide therapy (PRRT) over the past two decades are reviewed. Differences in kidney and bone marrow toxicity reported between (90)Y, (177)Lu and external beam radiotherapy (EBRT) are discussed with regard to the physical properties o...

Descripción completa

Detalles Bibliográficos
Autores principales: Walrand, Stephan, Jamar, François
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8347073/
https://www.ncbi.nlm.nih.gov/pubmed/34361092
http://dx.doi.org/10.3390/ijms22158326

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8347073/
https://www.ncbi.nlm.nih.gov/pubmed/34361092
http://dx.doi.org/10.3390/ijms22158326

Ejemplares similares